Comparing two methods of monitoring heart function during liver transplantation
Is Cardiac Index, Assessed by Transpulmonary Thermodilution, Reliable During Liver Transplantation Compared to Transesophageal Echocardiography : a Monocentric Cohort
This study is testing two different ways to monitor heart function during liver transplant surgery to see which method gives better information for doctors.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (France, Lyon) |
| Trial ID | NCT06899867 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare the effectiveness of two monitoring techniques, transpulmonary thermodilution and transesophageal echocardiography, in assessing cardiac index variations during liver transplantation. Patients undergoing liver transplantation will be monitored using both methods, with measurements taken at multiple time points throughout the surgical procedure. The goal is to identify any differences in cardiac index readings between the two techniques, which could inform better monitoring practices during surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who are scheduled to undergo liver transplantation.
Not a fit: Patients who have had recent esophageal varice ligation, mediastinal radiotherapy, or severe lower extremity artery disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve monitoring strategies during liver transplantation, leading to better patient outcomes.
How similar studies have performed: While there have been studies comparing monitoring techniques in various surgical settings, this specific comparison during liver transplantation is less common and may provide novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * liver transplantation * adults Exclusion Criteria: * \- Oesophageal varice ligation \< 14 days * Mediastinal radiotherapy * Femoral bypass * Severe lower extremity artery disease
Where this trial is running
France, Lyon
- Croix Rousse Hsopital — France, Lyon, France (Recruiting)
Study contacts
- Study coordinator: Pr Alice Blet
- Email: alice.blet@chu-lyon.fr
- Phone: 371239
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.